Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (300) Bromfenac, Duract, Wyeth-Ayerst Laboratories,
...Newly Approved Drug Therapies (300) Bromfenac, Duract, Wyeth-Ayerst Laboratories, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Bromfenac Company: Duract, Wyeth-Ayerst Laboratories Approval Status: Approved July 1997 Treatment Area: acute pain General ...
View Page

2.  CenterWatch: List of Newly Approved Drug Thearapies
...April 1997 Zenapax ; Roche; Treatment to prevent rejection of kidney transplants, Approved December 1997 Neurology Bromfenac ; Duract, Wyeth-Ayerst Laboratories; Management of acute pain, Approved July 1997 Carbatrol ; Elan Pharmaceuticals; Treatment ...
...estradiol, Approved December 1997 Oncology Anzemet ; Hoechst Marion Roussel; Treatment for emesis, Approved September 1997 Bromfenac ; Duract, Wyeth-Ayerst Laboratories; Management of acute pain, Approved July 1997 Femara (letrozole) ; Novartis; Treatment ...
View Page

3.  CenterWatch: Oncology Approved Drug Therapies
...1998 Drugs Approved in 1997 Anzemet ; Hoechst Marion Roussel; Treatment for emesis, Approved September 1997 Bromfenac ; Duract, Wyeth-Ayerst Laboratories; Management of acute pain, Approved July 1997 Femara (letrozole) ; Novartis; Treatment ...
View Page

4.  CenterWatch: Neurology Approved Drug Therapies
...1998 Tasmar ; Roche; Treatment for Parkinson's Disease, Approved January 1998 Drugs Approved in 1997 Bromfenac ; Duract, Wyeth-Ayerst Laboratories; Management of acute pain, Approved July 1997 Carbatrol ; Elan Pharmaceuticals; Treatment ...
View Page